The ACR/CHEST ILD Guidelines in Practice: Watch the Webinar Recording Now!

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hip OA

Opioid Makers Paid Millions to Advocacy Groups

Nate Raymond  |  

(Reuters)—Five opioid manufacturers, including OxyContin maker Purdue Pharma LP, have paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a U.S. Senate report said on Monday.1 The report, released by Sen. Claire McCaskill (D-Mo.), says groups who received the…

More Physical Activity Counseling Urged

  |  

New research from the CDC evaluated the prevalence of healthcare provider counseling for physical activity as a management strategy for arthritis. Researchers found that although healthcare provider counseling for exercise has increased during the past decade, 40% of patients with arthritis do not receive this counseling, resulting in a greater prevalence of physical inactivity for this patient population…

Arthritis Crisis: It’s Time to Act

  |  

Funding drives arthritis research breakthroughs and prevention programs, and advocates from the ACR, Arthritis Foundation and the National Recreation and Park Association (NRPA) pitched funding increases to lawmakers at a lunchtime briefing held Feb. 1 in Washington, D.C., in cooperation with the Congressional Arthritis Caucus. During the briefing, titled $300 Billion Crisis: The High Cost…

ACGME Milestones Debated at ACR: Does the Milestones System Ask too many Questions?

Larry Beresford  |  

Milestones are at the core of the current system designed to evaluate medical residency and fellowship programs and their participants. But are all milestones meaningful for medical education? This idea was at the center of a debate during the 2017 ACR/ARHP Annual Meeting, during which speakers explored the advantages and drawbacks of using training milestones for rheumatology fellowships…

Congress Urged to Fix CMS Rule Distorting Part B Drug Reimbursement

  |  

LATE-BREAKING NEWS Editor’s note: The ACR praises Congressional leaders for passing today’s (2/9) sweeping spending agreement, which includes a technical provision reversing a Centers for Medicare & Medicaid Services (CMS) policy that would have linked physicians’ quality payment adjustments to Medicare Part B drug costs starting in 2019. The ACR also applauded the inclusion of…

ACR in Action: A Look at ACR Activities That Support Your Practice

  |  

Rheumatologists working in every practice setting face a number of challenges that can seem insurmountable. How do you cost-effectively manage administrative burdens? How do you establish an efficient and effective approach to capturing quality metrics? How do you maintain the critical elements of the care you provide, such as diagnostic musculoskeletal ultrasound and patient access…

Potential Therapeutic Target for SpA

  |  

Innate lymphoid cells (ILCs) in the joints of patients may drive the pathology of spondyloarthritis through the production of granulocyte colony-stimulating factor (GM-CSF). A recent study found that both GM-CSF-producing CD4 T cells and the GM-CSF+ Th17 cells expressed high levels of GPR65—indicating that both GM-CSF and GPR65 may be therapeutic targets for spondyloarthritis…

Rheumatology Research Foundation Honors Award Recipients

  |  

SAN DIEGO—In November, the Rheumatology Research Foundation honored 155 award and scholarship recipients at the Awards Celebration, an annual luncheon, held in conjunction with the ACR/ARHP Annual Meeting. The event celebrates the accomplishments of rheumatology professionals who have received funding from the Foundation. In congratulating the award recipients, executive director Mary Wheatley, CAE, IOM, emphasized…